TY - JOUR
T1 - Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis
AU - Jandric, Danka
AU - Lipp, Ilona
AU - Paling, David
AU - Rog, David
AU - Castellazzi, Gloria
AU - Haroon, Hamied
AU - Parkes, Laura
AU - Parker, Geoff J.M.
AU - Tomassini, Valentina
AU - Muhlert, Nils
N1 - Funding Information:
D. Jandric and I. Lipp report no disclosures. D. Paling reports personal fees from Novartis, Biogen, Celgene, and Merck and grants and personal feels from Sanofi Genzyme outside the submitted work. D. Rog reports personal fees from Biogen, MedDay, Hikma Pharmaceuticals, Novartis, Roche, and Janssen-Cilag and grants and personal fees from Sanofi Genzyme outside the submitted work. G. Castellazzi, H. Haroon, and L. Parkes report no disclosures. G. Parker reports grants from the Medical Research Council during the conduct of the study and grants from the Engineering and Physical Sciences Research Council, outside the submitted work. Dr. Parker is director of and shareholder in Queen Square Analytics, a company with an interest in neuroimaging services, and is director of and shareholder in Bioxydyn, a company with an interest in neuroimaging services. V. Tomassini and N. Muhlert report no disclosures. Go to Neurology.org/N for full disclosures.
Funding Information:
This work was funded by a research grant of the MS Society UK and a Medical Research Council Doctoral Training Partnership grant (MR/N013751/11).
Publisher Copyright:
© American Academy of Neurology.
PY - 2021/11/9
Y1 - 2021/11/9
N2 - Background and ObjectivesCognitive impairment in multiple sclerosis MS is associated with functional connectivity abnormalities. While there have been calls to use functional connectivity measures as biomarkers, there remains to be a full understanding of why they are affected in MS. In this cross-sectional study, we tested the hypothesis that functional network regions may be susceptible to disease-related "wear and tear"and that this can be observable on co-occurring abnormalities on other magnetic resonance metrics. We tested whether functional connectivity abnormalities in cognitively impaired patients with MS co-occur with 1 overlapping, 2 local, or 3 distal changes in anatomic connectivity and cerebral blood flow abnormalities.MethodsMultimodal 3T MRI and assessment with the Brief Repeatable Battery of Neuropsychological tests were performed in 102 patients with relapsing-remitting MS and 27 healthy controls. Patients with MS were classified as cognitively impaired if they scored ≥1.5 SDs below the control mean on ≥2 tests n = 55 or as cognitively preserved n = 47. Functional connectivity was assessed with Independent Component Analysis and dual regression of resting-state fMRI images. Cerebral blood flow maps were estimated, and anatomic connectivity was assessed with anatomic connectivity mapping and fractional anisotropy of diffusion-weighted MRI. Changes in cerebral blood flow and anatomic connectivity were assessed within resting-state networks that showed functional connectivity abnormalities in cognitively impaired patients with MS.ResultsFunctional connectivity was significantly decreased in the anterior and posterior default mode networks and significantly increased in the right and left frontoparietal networks in cognitively impaired relative to cognitively preserved patients with MS threshold-free cluster enhancement corrected at p ≤ 0.05, 2 sided. Networks showing functional abnormalities showed altered cerebral blood flow and anatomic connectivity locally and distally but not in overlapping locations.DiscussionWe provide the first evidence that functional connectivity abnormalities are accompanied by local cerebral blood flow and structural connectivity abnormalities but also demonstrate that these effects do not occur in exactly the same location. Our findings suggest a possibly shared pathologic mechanism for altered functional connectivity in brain networks in MS.
AB - Background and ObjectivesCognitive impairment in multiple sclerosis MS is associated with functional connectivity abnormalities. While there have been calls to use functional connectivity measures as biomarkers, there remains to be a full understanding of why they are affected in MS. In this cross-sectional study, we tested the hypothesis that functional network regions may be susceptible to disease-related "wear and tear"and that this can be observable on co-occurring abnormalities on other magnetic resonance metrics. We tested whether functional connectivity abnormalities in cognitively impaired patients with MS co-occur with 1 overlapping, 2 local, or 3 distal changes in anatomic connectivity and cerebral blood flow abnormalities.MethodsMultimodal 3T MRI and assessment with the Brief Repeatable Battery of Neuropsychological tests were performed in 102 patients with relapsing-remitting MS and 27 healthy controls. Patients with MS were classified as cognitively impaired if they scored ≥1.5 SDs below the control mean on ≥2 tests n = 55 or as cognitively preserved n = 47. Functional connectivity was assessed with Independent Component Analysis and dual regression of resting-state fMRI images. Cerebral blood flow maps were estimated, and anatomic connectivity was assessed with anatomic connectivity mapping and fractional anisotropy of diffusion-weighted MRI. Changes in cerebral blood flow and anatomic connectivity were assessed within resting-state networks that showed functional connectivity abnormalities in cognitively impaired patients with MS.ResultsFunctional connectivity was significantly decreased in the anterior and posterior default mode networks and significantly increased in the right and left frontoparietal networks in cognitively impaired relative to cognitively preserved patients with MS threshold-free cluster enhancement corrected at p ≤ 0.05, 2 sided. Networks showing functional abnormalities showed altered cerebral blood flow and anatomic connectivity locally and distally but not in overlapping locations.DiscussionWe provide the first evidence that functional connectivity abnormalities are accompanied by local cerebral blood flow and structural connectivity abnormalities but also demonstrate that these effects do not occur in exactly the same location. Our findings suggest a possibly shared pathologic mechanism for altered functional connectivity in brain networks in MS.
UR - http://www.scopus.com/inward/record.url?scp=85118646989&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000012834
DO - 10.1212/WNL.0000000000012834
M3 - Article
C2 - 34649879
AN - SCOPUS:85118646989
SN - 0028-3878
VL - 97
SP - E1886-E1897
JO - Neurology
JF - Neurology
IS - 19
ER -